Global Primary Sclerosing Cholangitis (PSC) Market Set to Flourish, Predicted to Reach USD 314.26 Million by 2033

The global primary sclerosing cholangitis (PSC) market is on the brink of substantial growth, poised to attain a valuation of USD 314.26 million by 2033, with a noteworthy compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. This projection underscores a significant expansion attributed to the escalating prevalence of liver diseases worldwide and …

Global Primary Sclerosing Cholangitis (PSC) Market Expected to Reach US$ 314.26 Million by 2033

The global primary sclerosing cholangitis (PSC) market is poised for substantial growth, projected to reach US$ 314.26 million by 2033, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. This remarkable expansion is driven by the escalating prevalence of liver diseases worldwide and the burgeoning trend of alcohol consumption. In 2023, …

Global Primary Sclerosing Cholangitis (PSC) Market is poised to surpass US$ 314.26 Million by 2033, as projected by FMI

The global primary sclerosing cholangitis (PSC) market is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis (PSC) …